Legal & General Group
RGEN icon

Legal & General Group’s Repligen RGEN Stock Holding History

Legal & General Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.35M Sell
70,885
-7,918
-10% -$1.11M ﹤0.01% 1209
2025
Q4 		$12.9M Sell
78,803
-4,995
-6% -$782K ﹤0.01% 1028
2025
Q3 		$11.2M Sell
83,798
-2,407
-3% -$292K ﹤0.01% 1146
2025
Q2 		$10.7M Buy
86,205
+1,146
+1% +$146K ﹤0.01% 1143
2025
Q1 		$10.8M Buy
85,059
+3,155
+4% +$486K ﹤0.01% 1099
2024
Q4 		$11.8M Sell
81,904
-191
-0.2% -$27.4K ﹤0.01% 1091
2024
Q3 		$12.2M Sell
82,095
-71,005
-46% -$10.2M ﹤0.01% 1065
2024
Q2 		$19.3M Sell
153,100
-7,131
-4% -$1.12M 0.01% 840
2024
Q1 		$29.5M Sell
160,231
-3,017
-2% -$575K 0.01% 728
2023
Q4 		$29.4M Sell
163,248
-32,724
-17% -$5.09M 0.01% 732
2023
Q3 		$31.2M Sell
195,972
-2,928
-1% -$479K 0.01% 705
2023
Q2 		$28.1M Sell
198,900
-4,142
-2% -$664K 0.01% 746
2023
Q1 		$34.2M Buy
203,042
+1,670
+0.8% +$298K 0.01% 698
2022
Q4 		$34.1M Buy
201,372
+106,374
+112% +$19.3M 0.01% 690
2022
Q3 		$17.8M Buy
94,998
+14,110
+17% +$2.98M 0.01% 835
2022
Q2 		$13.1M Sell
80,888
-1,002
-1% -$158K ﹤0.01% 945
2022
Q1 		$15.4M Sell
81,890
-572
-0.7% -$109K ﹤0.01% 958
2021
Q4 		$21.8M Sell
82,462
-26,311
-24% -$7.09M 0.01% 882
2021
Q3 		$31.4M Buy
108,773
+39,015
+56% +$10M 0.01% 768
2021
Q2 		$13.9M Sell
69,758
-13,630
-16% -$2.64M ﹤0.01% 1017
2021
Q1 		$16.2M Buy
83,388
+3,434
+4% +$704K 0.01% 956
2020
Q4 		$15.3M Sell
79,954
-4,960
-6% -$902K 0.01% 925
2020
Q3 		$12.5M Buy
84,914
+4,551
+6% +$651K 0.01% 930
2020
Q2 		$9.93M Buy
80,363
+16,656
+26% +$1.96M ﹤0.01% 989
2020
Q1 		$6.15M Buy
63,707
+504
+0.8% +$48.7K ﹤0.01% 1068
2019
Q4 		$5.85M Buy
63,203
+3,353
+6% +$282K ﹤0.01% 1278
2019
Q3 		$4.59M Sell
59,850
-52,611
-47% -$4.6M ﹤0.01% 1342
2019
Q2 		$9.67M Buy
112,461
+11,545
+11% +$787K 0.01% 977
2019
Q1 		$5.96M Buy
100,916
+8,662
+9% +$498K ﹤0.01% 1078
2018
Q4 		$4.83M Buy
92,254
+1,869
+2% +$110K ﹤0.01% 1087
2018
Q3 		$4.98M Buy
90,385
+8,763
+11% +$452K ﹤0.01% 1178
2018
Q2 		$3.83M Buy
81,622
+4,528
+6% +$186K ﹤0.01% 1290
2018
Q1 		$2.77M Buy
77,094
+1,527
+2% +$53.7K ﹤0.01% 1441
2017
Q4 		$2.74M Buy
75,567
+640
+0.9% +$23.2K ﹤0.01% 1443
2017
Q3 		$2.87M Buy
74,927
+6,250
+9% +$262K ﹤0.01% 1375
2017
Q2 		$2.85M Buy
68,677
+9,121
+15% +$347K ﹤0.01% 1325
2017
Q1 		$2.09M Buy
59,556
+857
+1% +$27.1K ﹤0.01% 1451
2016
Q4 		$1.81M Buy
58,699
+27,074
+86% +$837K ﹤0.01% 1466
2016
Q3 		$952K Buy
31,625
+22,616
+251% +$682K ﹤0.01% 1416
2016
Q2 		$240K Buy
9,009
+2,272
+34% +$58.1K ﹤0.01% 1704
2016
Q1 		$184K Buy
6,737
+623
+10% +$15.2K ﹤0.01% 1769
2015
Q4 		$174K Hold
6,114
– – ﹤0.01% 1802
2015
Q3 		$171K Buy
6,114
+1,239
+25% +$44.8K ﹤0.01% 1775
2015
Q2 		$203K Hold
4,875
– – ﹤0.01% 1740
2015
Q1 		$148K Hold
4,875
– – ﹤0.01% 1804
2014
Q4 		$97K Hold
4,875
– – ﹤0.01% 1993
2014
Q3 		$97K Buy
+4,875
New +$103K ﹤0.01% 1900

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Legal & General Group's RGEN Position: Q1 2026 in Review

Legal & General Group reduced its Repligen (RGEN) stake by 10% in Q1 2026, selling an estimated $1.11M and leaving 70,885 shares worth $8.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Legal & General Group first reported a position in RGEN in Q3 2014 and has held it in 47 quarters since. The position peaked at $34.2M in Q1 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Legal & General Group held 70,885 shares of Repligen worth $8.35M as of Q1 2026.
  • Legal & General Group sold 7,918 Repligen shares in Q1 2026, an estimated $1.11M.
  • Repligen made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1209 holding.
  • Legal & General Group first reported a position in Repligen in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's Repligen position peaked at $34.2M in Q1 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.